Evidence map›Paper›PMID 19066956›Full record

ArticleEuropean journal of pediatrics2009

Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b.

D Melis, R Della Casa, R Parini, M Rigoldi, C Cacciapuoti, P Marcolongo, A Benedetti, V Gaudieri, G Andria, G Parenti

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Glycogen storage diseases: An update.World journal of gastroenterology · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Neutropenia in type Ib glycogen storage disease.Current opinion in hematology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

D MelisDepartment of Pediatrics, Federico II University, Via Sergio Pansini, 5, Naples 80131, Italy.
R Della Casa
R Parini
M Rigoldi
C Cacciapuoti
P Marcolongo
A Benedetti
V Gaudieri
G Andria
G Parenti
Federico II University Hospital · ITAzienda Ospedaliera San Gerardo · ITUniversity of Siena · IT

Funding

Telethon TGM06C05
6 · The paper itself

Abstract

backgroundNeutropenia and/or neutrophil dysfunction are part of glycogen storage disease type 1b (GSD1b) phenotype. Recent studies indicated that activation of apoptosis and increased reactive oxygen species are implicated in the pathogenesis of neutropenia in GSD1b.

methodsWe studied seven GSD1b patients over a 2-year-period to evaluate the efficacy of vitamin E, a known antioxidant, in preventing or improving the clinical manifestations associated with neutropenia and neutrophil dysfunction. Frequency and severity of infections, neutrophil counts and function, ileocolonoscopy and intestinal histology, were monitored. During the first year, patients did not assume vitamin E; during the second year of the study, vitamin E supplementation was added to their therapeutic regimens.

resultsDuring vitamin E supplementation, the mean values of neutrophil counts were significantly higher (p < 0.05) and neutrophil counts lower than 500/mm(3) were found less frequently (p < 0.05); the frequency and severity of infections, mouth ulcers and perianal lesions, was reduced (p < 0.05); ileocolonoscopy and histology showed a mild improvement. Vitamin E supplementation did not result in changes in neutrophil function.

conclusionsThese results suggest that vitamin E supplementation might be beneficial in GSD1b patients and may alleviate disease manifestations associated with neutropenia.

Indexed as

AdolescentAdultAntiportersBacterial InfectionsChildChild, PreschoolDNA Mutational AnalysisFemaleGlycogen Storage Disease Type IHumansMaleMonosaccharide Transport ProteinsNeutropeniaPoint MutationProspective StudiesTreatment OutcomeAntiportersMonosaccharide Transport ProteinsSLC37A4 protein, humanVitamin E

Identifiers

PMID19066956
OpenAlexW2085243155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.